| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K48477130 |
| PharmacoGx | BRD-K48477130 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MRPL32 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | LZTS2 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | C2orf50 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | ZNF430 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | TMEM200C | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | TOMM7 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | ATP6AP2 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | SEC16A | CTRPv2 | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | NDFIP1 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | PFDN2 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.001 |
